Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts
- PMID: 11565520
- DOI: 10.1056/NEJMoa010212
Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts
Abstract
Background: Infection with the larval form of the pork tapeworm, Taenia solium, can lead to the development of cysts in the brain. Surgical removal of cysts has been the accepted treatment for neurocysticercosis characterized by giant cysts when there is associated intracranial hypertension.
Methods: We describe 33 patients whom we treated medically for malignant forms of neurocysticercosis. All patients had evidence of intracranial hypertension and subarachnoid cysts at least 50 mm in diameter. All patients received 15 mg of albendazole per kilogram of body weight per day for four weeks. Ten patients were also treated with 100 mg of praziquantel per kilogram per day for four weeks. Seventeen patients received a second course of albendazole, three received a third course, and one received a fourth course. During the first cycle of treatment, all patients also received dexamethasone. Five patients had previously undergone neurosurgery for giant cysts.
Results: After a median of 59 months of follow-up (range, 7 to 102), the condition of all 33 patients had improved, and the cysts had disappeared or become calcified. Of the 22 patients with a history of seizures, only 11 continued to receive antiseizure medications. The median quality-of-life score on the Karnofsky scale improved from 40 to 100. Fifteen patients received a ventriculoperitoneal shunt because of hydrocephalus. Four patients had persistent sequelae (bilateral partial optic atrophy, stroke, or diplopia) of the cysts.
Conclusions: Intensive medical treatment can be effective in patients with neurocysticercosis characterized by giant cysts. Neurosurgery may be required only when there is an imminent risk of death.
Similar articles
-
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.N Engl J Med. 2004 Jan 15;350(3):249-58. doi: 10.1056/NEJMoa031294. N Engl J Med. 2004. PMID: 14724304 Clinical Trial.
-
[Clinical study on the treatment of severe neurocysticercosis].Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2004 Aug;22(4):213-7. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2004. PMID: 15587154 Chinese.
-
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.Neurology. 2006 Feb 14;66(3):436-8. doi: 10.1212/01.wnl.0000195887.63124.dc. Epub 2005 Dec 28. Neurology. 2006. PMID: 16382035 Clinical Trial.
-
Anthelmintics for people with neurocysticercosis.Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD000215. doi: 10.1002/14651858.CD000215.pub5. Cochrane Database Syst Rev. 2021. PMID: 34060667 Free PMC article.
-
Surgical management of neurocysticercosis.Int J Surg. 2010;8(2):100-4. doi: 10.1016/j.ijsu.2009.12.006. Epub 2010 Jan 4. Int J Surg. 2010. PMID: 20045747 Review.
Cited by
-
Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis.AJNR Am J Neuroradiol. 2004 Feb;25(2):295-7. AJNR Am J Neuroradiol. 2004. PMID: 14970035 Free PMC article.
-
A fatal case of malignant neurocysticercosis.BMJ Case Rep. 2017 Sep 27;2017:bcr2017222281. doi: 10.1136/bcr-2017-222281. BMJ Case Rep. 2017. PMID: 28954760 Free PMC article. No abstract available.
-
Cysticercosis of the central nervous system: how should it be managed?Curr Opin Infect Dis. 2011 Oct;24(5):423-7. doi: 10.1097/QCO.0b013e32834a1b20. Curr Opin Infect Dis. 2011. PMID: 21788891 Free PMC article. Review.
-
Extraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive Review.J Clin Neurol. 2015 Jul;11(3):203-11. doi: 10.3988/jcn.2015.11.3.203. Epub 2015 May 28. J Clin Neurol. 2015. PMID: 26022457 Free PMC article. Review.
-
Current status and future perspectives on the medical treatment of neurocysticercosis.Pathog Glob Health. 2012 Sep;106(5):305-9. doi: 10.1179/2047773212Y.0000000046. Pathog Glob Health. 2012. PMID: 23265555 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical